Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|CC214-2||mTOR Inhibitor 51||CC214-2 is an ATP-competitive mTOR inhibitor, which inhibits signaling through mTORC1 and mTORC2, potentially resulting in decreased tumor cell growth (PMID: 24030701, PMID: 23414803).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||prostate cancer||not applicable||CC214-2||Preclinical - Cell line xenograft||Actionable||In a preclinical study, prostate cancer cell line xenograft models demonstrated inhibition of tumor growth when treated with CC214-2 (PMID: 23414803).||23414803|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|